Start / Cell & Gene: The Podcast / Gene therapy deals collaborations partnerships with astellas richard wilson

Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson

25 min • 21 november 2023

We love to hear from our listeners. Send us a message.

Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation at Astellas sat down with Cell & Gene: The Podcast's Erin Harris at ARM's 2023 Meeting on the Mesa to discuss the gene therapy deal making landscape as well as Astellas' recent deals and collaborations. They also discussed Astellas' strategic approach since having acquired Audentes back in 2020.

Subscribe to the podcast!
Apple | Spotify | YouTube

Visit my website: Cell & Gene

Connect with me on LinkedIn

Senaste avsnitt

Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.

17 juli | 25 min

Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

3 juli | 20 min

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

19 juni | 16 min

Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

5 juni | 25 min

Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder

22 maj | 19 min

Redefining Heart Failure Treatment with Precision Autologous Cell Therapy with BioCardia's Peter Altman, Ph.D.

8 maj | 18 min

CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.

27 februari | 29 min

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

13 februari | 36 min

The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.

30 januari | 27 min

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

16 januari | 24 min

Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

2 januari | 15 min

Can Gene Therapy Be the Solution for CHF with AskBio's Dr. Lothar Roessig

19 december 2024 | 21 min

Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rahkit

5 december 2024 | 31 min

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

21 november 2024 | 22 min

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

7 november 2024 | 21 min

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

24 oktober 2024 | 25 min

Pioneering Next-Gen TCR Therapies in Solid Tumors with Neogene Therapeutics’ Carsten Linnemann, Ph.D.

10 oktober 2024 | 14 min

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

25 september 2024 | 22 min

A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

12 september 2024 | 28 min

Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

29 augusti 2024 | 25 min

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

15 augusti 2024 | 28 min

Identifying Drug Development Opportunities for DMD with CureDuchenne

1 augusti 2024 | 30 min

Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

18 juli 2024 | 21 min

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

4 juli 2024 | 36 min

Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft

20 juni 2024 | 28 min

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

6 juni 2024 | 15 min

The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

28 maj 2024 | 25 min

Dr. Bruce Levine on ISCT and the Future of CAR-T

23 maj 2024 | 32 min

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

9 maj 2024 | 19 min

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

25 april 2024 | 30 min

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

11 april 2024 | 23 min

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

28 mars 2024 | 20 min

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

14 mars 2024 | 17 min

The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz

29 februari 2024 | 28 min

Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead company's Christopher McDonald

15 februari 2024 | 21 min

Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

1 februari 2024 | 37 min

Breaking Down Solid Tumors with Triumvira Immunologics' Dr. Paul Lammers

18 januari 2024 | 22 min

4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.

4 januari 2024 | 32 min

Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst

21 december 2023 | 14 min

Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D.

7 december 2023 | 17 min